Newer developments in therapy for endemic mycoses

Clinical Infectious Diseases

Volumn 19, Issue , 1994, Pages S28-S32

  Kauffman, Carol A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE; KETOCONAZOLE;

BLASTOMYCES DERMATITIDIS; BLASTOMYCOSIS; CONFERENCE PAPER; DRUG EFFICACY; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SPOROTHRIX SCHENCKII; SPOROTRICHOSIS;

ANTIFUNGAL AGENTS; BLASTOMYCOSIS; HISTOPLASMOSIS; HUMAN; ITRACONAZOLE; MYCOSES; SPOROTRICHOSIS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027938352     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/19.Supplement_1.S28     Document Type: Article

References (34)

1. Galgiani JN. Coccidioidomycosis. West J Med 1993;159:153-71.
2. Furcolow ML. Comparison of treated and untreated severe histoplasmosis. JAMA 1963;183:823-9.
3. Parker JD, Sarosi GA, Doto IL, Bailey RE, Tosh FE. Treatment of chronic pulmonary histoplasmosis. A National Communicable Disease Center cooperative mycoses study. N Engl J Med 1970; 283:225-9.
4. Reddy P, Gorelick DK, Brasher CA, Larsh H. Progressive disseminated histoplasmosis as seen in adults. Am J Med 1970;48:629-36.
5. Smith JW, Utz JP. Progressive disseminated histoplasmosis. A prospective study of 26 patients. Ann Intern Med 1972;76:557-65.
6. Blastomycosis Cooperative Study of the Veterans Administration. Blastomycosis: a review of 198 collected cases in Veterans Administration Hospitals. Am Rev Resp Dis 1964;89:659-72.
7. Busey JF. Blastomycosis. III. A comparative study of 2-hydroxystilba-midine and amphotericin B therapy. Am Rev Resp Dis 1972; 105:812-8.
8. Wheat IJ. Histoplasmosis—diagnosis and management. Infect Dis Clin Prac 1992;1:277-80.
9. Tenebaum MJ, Greenspan J, Kerkering TM. Blastomycosis. CRC Crit Rev Microbiol 1982;9:139-63.
10. Kwon-Chung KJ. Bennett JE. Sporotrichosis. In: Medical mycology. Philadelphia: Lea &Febiger, 1992:707-29.
11. Parker JD, Sarosi GA, Tosh FE. Treatment of extracutaneous sporotrichosis. Arch Intern Med 1970;125:858-63.
12. Pluss JL, Opal SM. Pulmonary sporotrichosis: review of treatment and outcome. Medicine (Baltimore) 1986;65:143-53.
13. Dismukes WE, Stamm AM, Graybill JR. et al. Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. Ann Intern Med 1983;98:13-20.
14. Dismukes WE, Cloud G, Bowles C, et al. Treatment of blastomycosis and histoplasmosis with ketoconazole: results of a prospective randomized clinical trial. Ann Intern Med 1985;103:861-72.
15. Bradsher RW, Rice DC, Abernathy RS. Ketoconazole therapy for endemic blastomycosis. Ann Intern Med 1985;103:872-9.
16. Pont A, Graybill JR. Craven PC, et al. High dose ketoconazole therapy and adrenal and testicular function in humans. Arch Intern Med 1984;144:2150-3.
17. Dali L, Salzman G. Treatment of pulmonary sporotrichosis with ketoconazole. Rev Infect Dis 1987;9:795-8.
18. Horsburgh CR Jr, Cannady PB Jr, Kirkpatrick CH. Treatment of fungal infections in the bones and joints with ketoconazole. J Infect Dis 1983;147:1064-9.
19. Calhoun DL, Waskin H. White MP, et al. Treatment of systemic sporotrichosis with ketoconazole. Rev Infect Dis 1991;13:47-51.
20. Dismukes WE, Bradsher RW Jr. Cloud GC, et al. Itraconazole therapy for blastomycosis and histoplasmosis. Am J Med 1992;93:489-97.
21. Restrepo A, Robledo J. Gomez I, Tabares AM, Gutierrez R. Itraconazole therapy in lymphangitic and cutaneous sporotrichosis. Arch Dermatol 1986;122:413-7.
22. Sharkey-Mathis PK, Kauffman CA, Graybill JR, et al. Treatment of sporotrichosis with itraconazole. Am J Med 1993;95:279-85.
23. Tucker RM, Haq Y, Denning DW. Stevens DA. Adverse events associated with itraconazole in 189 patients on chronic therapy. J Anti-microb Chemother 1990;26:561-6.
24. Diaz M, Negroni R, Montero-Gei F, et al. A Pan-American 5-year study of fluconazole therapy for deep mycoses in the immunocompetent host. Clin Infect Dis 1992; 14(suppl 1):S68—76.
25. Pappas PG, Kauffman CA, Perfect J, et al. Fluconazole for the treatment of sporotrichosis [abstract no. 629], In: Programs and abstracts of the 32nd Interscicnce Conference on Antimicrobial Agents and Chemotherapy (Anaheim). Washington, DC: American Society for Microbiology, 1992.
26. Pappas PG, Bradsher RW, Chapman SW. et al. Fluconazole in the treatment of blastomycosis [abstract no, 1159], In: Programs and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 1991.
27. Wheat LJ, Connolly-Stringfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 1990;69:361-74.
28. Johnson PC, Khardori N, Najjar AF, Butt F, Mansell PW, Sarosi GA. Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Am J Med 1988;85:152-8.
29. McKinsey DS, Gupta MR, Driks MR, Smith DL, O’Connor M. Histoplasmosis in patients with AIDS: efficacy of maintenance amphotericin B therapy. Am J Med 1992;92:225-7.
30. Wheat J, Hafner R, Wulfsohn M, et al. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1993; 118:610-6.
31. Wheat LJ. Hafner RE, Ritchie M. Schneider D. Itraconazole (Itra) is effective treatment for histoplasmosis in AIDS: prospective multicenter non-comparative trial [abstract no. 1206], In: Programs and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy (Anaheim). Washington, DC: American Society for Microbiology, 1992.
32. Bradsher RW. Clinical considerations in blastomycosis. Infect Dis Clin Prac 1992;1:97-104.
33. Goodwin RA, Shapiro JL, Thurman GH, Thurman SS, Des Prez RM. Disseminated histoplasmosis: clinical and pathologic correlations. Medicine (Baltimore) 1980;59:1-33.
34. Goodwin RA, Owens FT, Snell JD, et al. Chronic pulmonary histoplasmosis. Medicine (Baltimore) 1976;55:413-51.